Global Preterm Birth Diagnostic Test Kits Market is valued approximately USD xx billion in 2020 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2021-2027. Preterm birth, also known as neonatal birth, occurs when a baby is born before the 37th week of pregnancy. Preterm birth diagnostic tests are widely used to prevent and manage premature births, which is driving the market for preterm birth diagnostic test kits to rise. The factors driving the growth of this market are the ever-increasing high birth rate in developing and developed countries, the rising prevalence of premature births, technological advancements in preterm birth diagnostic tests due to heavy investments in research and development activities, and government initiatives to increase neonatal survival rates. According to UNICEF (United Nations International Children's Emergency Fund) figures, around 2.5 million children died in the first four weeks following birth around the world in 2017. In 2017, there were approximately 115.4 million births, with 11.1 percent of those being premature, or around 12.8 million births. However, high premature birth investment, high entrance barriers owing to regulatory compliances, a lack of technical competent staff, and inadequate neonatal care accessibility, particularly in developing nations, are all factors that could stifle business growth. Moreover, high birth rate in developing countries such as India, Brazil, China, and Other offers opportunities during the forecasting years.

The key regions considered for the global Preterm Birth Diagnostic Test Kits market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world in terms of market share owing to the increasing high birth rate in developing and developed countries, the rising prevalence of premature births. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2021-2027.

Major market player included in this report are:

Qiagen

Medix Biochemica

Hologic Inc.

Sera Prognostics

IQ Products

Creative Diagnostics

Nanjing Liming Biological Preparations Co., Ltd.

Clinical Innovations, LLC

Bioserv Diagnostic GmbH

Abbott

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Fetal Fibronectin Test Kits (fFN)

Placental Alpha Micro-globulin-1 test kits (PAMG-1)

Insulin like Growth Factor Binding Protein-1 test kits (IGFBP-1)

Others

By Sample:

Blood Sample

Urine Sample

Vaginal Discharge Sample

By End User:

Hospitals

Diagnostic Laboratories

Pediatric and Neonatal Clinics

Other

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Preterm Birth Diagnostic Test Kits Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors